$32.21 0%
Price vs. AI Score (Last 150 days)
Data gathered: November 30

Data Bits

Data Bits Value / Change Benchmark
Job Posts 18 5.9%
Sentiment 54 0%
Webpage traffic 38,000 6.9%
Employee Rating 62 0%
4chan Mentions 0%
Facebook Engagement 16 100%
Facebook followers 605 0%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 3,163 0.1%
Twitter Followers 1,553 -0.1%
Youtube Subscribers 404 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 43 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Cytokinetics

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Price $32.21
Target Price Sign up
Market Cap $3.12B
Dividend Yield 0.0146
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23380,00040M-47M-129M-115M
Q2 '23870,00040M-46M-129M-115M
Q1 '234.6M50M-52M-131M-118M
Q4 '222M54M-59M-137M-121M
Q3 '222.5M48M-53M-142M-103M

Insider Transactions

Malik Fady Ibraham filed to sell 150,664 shares at $35.4.
November 9 '23
Blum Robert I filed to sell 441,417 shares at $32.2.
October 30 '23
Blum Robert I filed to sell 441,417 shares at $33.7.
October 16 '23
Malik Fady Ibraham filed to sell 153,164 shares at $35.9.
October 12 '23
Blum Robert I filed to sell 441,417 shares at $30.
October 6 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.